NSC |
Compound |
Enrichment |
Correlation |
NSC 135687 |
5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) |
0.0247979034812109 |
0.020602618 |
NSC 154948 |
M-AMSA |
0.0247979034812109 |
-0.033961986 |
NSC 185065 |
Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- |
0.0247979034812109 |
0.15269712 |
NSC 18805 |
.gamma.-Thujaplicine |
0.0247979034812109 |
0.35911845 |
NSC 22709 |
v-Triazolo[4,5-d]pyrimidin-7-ol |
0.0247979034812109 |
0.18184056 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.0247979034812109 |
0.20781165 |
NSC 303861 |
L-Cysteine analog |
0.0247979034812109 |
0.26777652 |
NSC 30722 |
Pyrimidine, 2,4,6-trichloro-5-methyl- |
0.0247979034812109 |
0.11519792 |
NSC 339137 |
PHYSALOLACTONE |
0.0247979034812109 |
0.049260719 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0247979034812109 |
0.064895692 |